Get the Stockscreener App
24.16
2.94%
0.69
Staar Surgical Co stock is traded at $24.16, with a volume of 1.40M.
It is up +2.94% in the last 24 hours and down -0.21% over the past month.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
See More
Previous Close:
$23.47
Open:
$23.14
24h Volume:
1.40M
Relative Volume:
1.65
Market Cap:
$1.21B
Revenue:
$290.38M
Net Income/Loss:
$-21.03M
P/E Ratio:
-56.26
EPS:
-0.4294
Net Cash Flow:
$-54.99M
1W Performance:
+2.72%
1M Performance:
-0.21%
6M Performance:
+30.88%
1Y Performance:
-12.75%
1-Day Range:
$22.66
$24.36
1-Week Range:
$22.66
$24.36
52-Week Range:
$15.59
$35.87
Staar Surgical Co Stock (STAA) Company Profile
Name
Staar Surgical Co
Sector
Industry
Phone
(626) 303-7902
Address
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
24.16 | 1.18B | 290.38M | -21.03M | -54.99M | -0.4294 |
ISRG
Intuitive Surgical Inc
|
350.16 | 129.55B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
179.10 | 50.32B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
69.12 | 34.08B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
221.05 | 32.94B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.69 | 32.10B | 29.14B | 1.07B | 1.05B | 1.1956 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-26 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-03-26 | Initiated | Wedbush | Neutral |
| Jan-16-26 | Resumed | Morgan Stanley | Underweight |
| Apr-21-25 | Initiated | Wells Fargo | Equal Weight |
| Feb-12-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-12-25 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-25 | Downgrade | Mizuho | Outperform → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-11-24 | Upgrade | BTIG Research | Neutral → Buy |
| Mar-11-24 | Upgrade | Stifel | Hold → Buy |
| Dec-05-23 | Downgrade | Needham | Buy → Hold |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-03-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jun-07-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-17-23 | Initiated | Piper Sandler | Neutral |
| Feb-06-23 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-28-22 | Reiterated | BTIG Research | Buy |
| Dec-08-22 | Initiated | Stifel | Hold |
| Nov-07-22 | Upgrade | Sidoti | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-28-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-09-21 | Initiated | Oppenheimer | Perform |
| Jan-19-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-26-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-31-20 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-20 | Reiterated | The Benchmark Company | Buy |
| Jul-06-20 | Downgrade | Sidoti | Buy → Neutral |
| Jun-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-15-20 | Initiated | Jefferies | Buy |
| Dec-04-19 | Initiated | BTIG Research | Buy |
| Sep-24-18 | Reiterated | The Benchmark Company | Buy |
| Aug-06-18 | Resumed | The Benchmark Company | Buy |
| Nov-20-17 | Reiterated | The Benchmark Company | Buy |
| Aug-14-17 | Reiterated | The Benchmark Company | Buy |
| Mar-03-17 | Reiterated | The Benchmark Company | Buy |
| May-18-16 | Upgrade | The Benchmark Company | Hold → Buy |
| Sep-10-13 | Resumed | The Benchmark Company | Buy |
| Feb-28-13 | Reiterated | The Benchmark Company | Buy |
| Nov-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-12 | Initiated | Northland Securities | Outperform |
| Oct-25-11 | Reiterated | The Benchmark Company | Buy |
| Oct-12-10 | Initiated | Morgan Joseph | Buy |
| May-11-10 | Initiated | Benchmark | Buy |
View All
Staar Surgical Co Stock (STAA) Latest News
Former CEO returns as STAAR's vision-lens revenue grows more than tenfold - Stock Titan
Leadership watch: Samsara, Claris Bio, Staar Surgical, Wills Eye, and more - Glance by Eyes On Eyecare
Why Did STAA Stock Surge More Than 19% After-Hours Today? - Stocktwits
STAAR Surgical names Ben Park as CTO - medicalbuyer.co.in
STAAR Surgical Appoints Ben Park as Chief Technology Officer - VisionMonday.com
STAAR Surgical Hires Align Exec Dr. Ben Park as CTO - Medical Product Outsourcing
STAAR Surgical Company Announces Appointment of Ben Park as Chief Technology Officer - marketscreener.com
STAA Looks 30.9% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
Is STAAR Surgical (STAA) Cheap Following Its Recent Share Price Slide? - simplywall.st
STAAR Surgical Company (STAA) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
STAAR Surgical Names Warren Foust President and Chief Executive Officer - thekeyexecutives.com
Madison Avenue Partners, LP Buys Staar Surgical Co (STAA) -- Sha - GuruFocus
STAAR (STAA) Q2 2026 Earnings Call Transcript - The Globe and Mail
5 Insightful Analyst Questions From STAAR Surgical’s Q2 Earnings Call - Yahoo Finance
STAAR Surgical CEO Warren Foust Reports PSU Vesting and New Equity Grants on August 14, 2026 - Kalkine Media
STAAR Surgical CFO Deborah Andrews Reports August 2026 Stock Vesting and New Equity Grants - Kalkine Media
STAAR Surgical (STAA) awards CFO RSUs, options and PSUs - Stock Titan
STAA Stock On Track For Its Fourth Straight Session Of Gains – This Analyst Would Rather Be Early Than Late On Staar’s Growth Story - Stocktwits
Midday Stock Roundup: Indie Semi Falls - Orange County Business Journal
Why STAAR Surgical (STAA) Shares Are Sliding Today - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
STAAR Surgical (NASDAQ:STAA) Shares Down 6.6% Following Analyst Downgrade - MarketBeat
Deciphering Staar Surgical (STAA) International Revenue Trends - Yahoo Finance
Stifel cuts Staar Surgical stock price target on China concerns By Investing.com - Investing.com Australia
Stifel cuts Staar Surgical stock price target on China concerns - Investing.com
Stifel Nicolaus Lowers STAAR Surgical (NASDAQ:STAA) Price Target to $28.00 - MarketBeat
Staar Surgical Appoints Warren Foust as President and CEO - Eyewire+
Is STAAR Surgical (STAA) Still Below Fair Value After Its Return To Profit? - Yahoo Finance
Why STAAR Surgical (STAA) Is Up 8.1% After Returning To Profit Under New CEO Warren Foust – And What's Next - simplywall.st
STAA Q2 Deep Dive: China Demand and Product Expansion Drive Revenue Growth Amid Market Caution - Yahoo Finance
Why STAAR Surgical (STAA) Is Up 8.1% After Q2 Profit Rebound And New CEO Appointment - Yahoo Finance
STAAR Surgical (STAA) Gives Warren Foust The CEO Role After Its Profit Reset - Yahoo Finance
STAAR Surgical (STAA) Stock May Be 13% Below Fair Value Following Q2 Earnings Preview - Yahoo Finance
Quantinno Capital Management LP Takes $1.11 Million Position in STAAR Surgical Company $STAA - MarketBeat
Staar Surgical Co (STAA) Shares Surge 3.4% -- What GF Score of 8 - GuruFocus
STAAR Surgical (STAA) reports 8.4% stake held by Madison Avenue group - Stock Titan
STAAR Surgical (STAA) Stock Price Shrugs Off Profit Rebound As China Dominates - simplywall.st
STAAR Surgical earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Jefferies cuts STAAR Surgical stock price target on estimate update By Investing.com - Investing.com South Africa
STAA Maintains Rating by UBS -- Price Target Lowered to $19.00 - GuruFocus
Jefferies cuts STAAR Surgical stock price target on estimate update - Investing.com
STAA Maintained by Wedbush -- Price Target Lowered to $37.00 - GuruFocus
Piper Sandler reiterates Neutral on STAAR Surgical stock at $33 By Investing.com - Investing.com South Africa
Piper Sandler reiterates Neutral on STAAR Surgical stock at $33 - Investing.com
STAAR Surgical (NASDAQ:STAA) Price Target Lowered to $37.00 at Wedbush - MarketBeat
STAAR Surgical Company Q2 2026 Earnings Call Summary - Yahoo Finance
Staar Surgical Co (STAA) (Q2 2026) Earnings Call Highlights: Record Revenue Surge and Strategic ... - Yahoo Finance
STAA SWOT Analysis: Strong Financial Recovery Revealed in 10-Q F - GuruFocus
STAA Looks 19.9% Undervalued on GF Value™ - GuruFocus
Why STAAR Surgical (STAA) Is Getting Fresh Attention Now - simplywall.st
Earnings call transcript: STAAR Surgical tops revenue views in Q2 2026 - Investing.com Nigeria
Staar Surgical Co Stock (STAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):